Medx | Celgene | Medarex

The Independent reported on Saturday that patients with an inoperable prostate disease have recovered after a single dose of an experimental drug developed by Medarex Inc. (NYSE: MEDX ) and Bristol-Myers Squibb Co. (NYSE: BMY).